eVAC Wins Energy Transition Deal of the Year for U.S. Permanent Magnet Manufacturing Facility
HOUSTON and BOSTON, March 18, 2025 /PRNewswire/ -- Ara Partners, a global private equity firm dedicated to decarbonizing the industrial economy, announced that e-VAC Magnetics, LLC ('eVAC') has been awarded IJ Global's 2024 Energy Transition Deal of the Year (North America). The award recognizes eVac's $335 million non-recourse financing for their first-of-its-kind U.S. permanent magnet manufacturing facility in Sumter County, South Carolina. The transaction has also been recognized by Proximo as the North American Manufacturing Deal of the Year.
This landmark transaction, undertaken by Ara Partners and its portfolio company Vacuumschmelze GmbH & Co. KG ('VAC'), strengthens the domestic supply chain for electric vehicles, aerospace and defense, renewable energy, and other critical industries.
'We are honored that eVAC's financing has been recognized as IJ Global's 2024 Energy Transition Deal of the Year,' said Tuan Tran, Senior Managing Director. 'This transaction underscores the finance market's confidence in Ara's ability to scale world-class manufacturing that supports both the energy transition and U.S. supply chain security. We deeply appreciate the trust and support of our financing partners, as well as the broader ecosystem of stakeholders who made this possible.'
The financing was led by BMO and Mitsubishi UFJ Financial Group, Inc. ('MUFG'), with Canadian Imperial Bank of Commerce ('CIBC'), Coöperatieve Rabobank U.A. ('Rabobank'), and Société Générale S.A. ('Société Générale') as Coordinating Lead Arrangers.
The eVAC facility was established through a strategic partnership with General Motors ('GM') to supply rare earth permanent magnets for GM's electric vehicles over the next decade. The project has also received strong federal and state support, including a Defense Production Act Title III grant from the Department of Defense and a $111.9 million Qualifying Advanced Energy Project Tax Credit.
PEI Global Partners LLC ('PEI') served as Exclusive Financial Advisor to Ara Partners and VAC on the transaction. Latham & Watkins LLP served as borrower counsel, while Milbank LLP served as lenders counsel.
'PEI is proud to have supported this award-winning transaction, which demonstrates our firm's ingenuity, deep industry relationships and focus on delivering an optimal outcome for our clients,' said Sky Fabian, Partner at PEI. 'A collaborative effort among Ara Partners, eVAC, the banks, lawyers and advisors enabled a first-of-a-kind transaction that will serve as a blueprint for advanced manufacturing financing going forward. We sincerely thank everyone involved for their trust, commitment and tireless efforts in getting this transaction across the finish line.'
'We are truly honored by this award, which recognizes the bold vision and unwavering dedication behind our e-VAC project in the United States,' noted Erik Eschen, CEO of VAC. 'This investment secures North America's supply chain and drives re-industrialization, demonstrating the power of collaboration among industry, policymakers, investors, and communities. By pushing the boundaries of innovation and forging strategic partnerships, we have proven that even the most ambitious projects can be realized within a short timeframe when collaboration drives progress.'
This recognition from IJ Global, a leading publication covering global infrastructure and energy finance, highlights the groundbreaking nature of eVAC's financing structure and its role in advancing sustainable industrial manufacturing in North America.
About Vacuumschmelze
Vacuumschmelze ('VAC') is a leading global producer of advanced magnetic solutions, rare earth permanent magnets, and inductive components that are crucial for the decarbonization of our planet. With more than 100 years of application know-how and experience in material science and product development, VAC designs and manufactures mission critical solutions for a wide variety of industries, including renewable energy, e-mobility, automotive, industrial automation, medical, aerospace and defense. VAC's unique ability to develop and manufacture from base elements through final products enables us to provide customers with optimal form factors and performance, generating best in class efficient solutions in an environmentally conscious manner.
More information at .
About Ara Partners
Ara Partners is a global private equity and infrastructure investment firm focused on industrial decarbonization. Founded in 2017, Ara Partners seeks to build and scale companies with significant decarbonization impact across the industrial and manufacturing, chemicals and materials, energy efficiency and green fuels, and food and agriculture sectors. The company operates from offices in Houston, Boston, Washington, D.C., and Dublin. Ara Partners closed its third private equity fund in December 2023 with over $2.8 billion in capital commitments. As of September 2024, Ara Partners had approximately $6.3 billion of assets under management.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
22-05-2025
- Business Wire
L3Harris Marks Major Milestone for New Solid Rocket Motor ‘Factories of the Future' in Virginia
CULPEPER, Va.--(BUSINESS WIRE)--L3Harris Technologies (NYSE: LHX) has broken ground on the construction of five new solid rocket motor facilities in Virginia that will boost production to support key national defense programs. The new facilities will incorporate modular factory design, robotic flex cells, automated, progressive casting and improved handling and assembly throughout the production line. 'L3Harris' growth in Virginia is another solid example of how we're expanding our rocket motor manufacturing infrastructure to support the nation's defense propulsion needs,' said Ken Bedingfield, President, Aerojet Rocketdyne, L3Harris. 'Made possible through a Defense Production Act Title III cooperative agreement, this expansion will complement an existing 256,000 square feet of manufacturing space, supporting some of the most advanced propulsion research and production in the world.' L3Harris' site in Virginia hosts the company's Center of Excellence for Propellant Research and Small to Medium-sized Solid Rocket Motor Production. The expansion includes a 12,000 square foot, state-of-the-art solid rocket motor cast and assembly facility, as well as a control room, facilities to support mixing and grinding operations and upgrades to the site's motor testing capabilities. The consolidated cast and assembly building will centralize production of a critical program under one roof, reducing the distance motors travel during manufacturing by 90%. 'L3Harris' continued expansion in Virginia underscores the Commonwealth's pivotal role in safeguarding our nation's security,' said Virginia Gov. Glenn Youngkin. 'With a world-class workforce, cutting-edge infrastructure, and a strategic East Coast location, Virginia offers the ideal environment for defense and aerospace leaders like L3Harris to grow and drive innovation for the future.' 'I'm proud of Virginia's continued leadership in the defense sector, which is made possible in part through crucial investments like L3Harris' new solid rocket motor facilities,' said Sen. Tim Kaine, D-Va. 'I'll keep looking for opportunities to support Virginia's robust defense industry—a core pillar of Virginia's economy and a key component of our military readiness.' 'Thrilled to see L3Harris expand its presence in Virginia and continue to strengthen our defense industrial base,' said Sen. Mark R. Warner, D-Va. 'This investment in Orange County will support the world-class research and manufacturing coming out of Virginia, while also creating valuable jobs for American workers.' 'This investment by L3Harris underscores how the Seventh Congressional District, and Virginia overall, remains a great place to build systems critical to our national security. This project will yield exactly the kind of smart, strategic growth we need in the Seventh District to strengthen our national security, rebuild America's defense industrial base, and build key components for munitions such as the Javelin,' said Rep. Eugene Vindman, D-Va. 'As an Army veteran and a member of the House Armed Services Committee, I will prioritize supporting projects that ensure our service members have the tools they need to keep our country safe — while creating more good jobs right here in the Seventh.' 'Investment in key capabilities for domestic defense production is integral to our efforts to continue to support warfighter requirements,' said Greg Davis, Acting Director, Manufacturing Capability Expansion and Investment Prioritization, Office of the Assistant Secretary of Defense for Industrial Base Policy. 'It's also an important component to the Department's priority of revitalizing the defense industrial base.' L3Harris is also modernizing and expanding its solid rocket motor production in two other states. The company is constructing new solid rocket motor facilities in Camden, Arkansas, and is transitioning production of inert components for critical missile systems to align with the sites' core competencies in Huntsville, Alabama. The company is already ramping up production due to digital process improvements as well as new tooling and equipment. About L3Harris Technologies L3Harris Technologies is the Trusted Disruptor in the defense industry. With customers' mission-critical needs always in mind, our employees deliver end-to-end technology solutions connecting the space, air, land, sea and cyber domains in the interest of national security. Visit for more information. Forward-Looking Statements This press release contains forward-looking statements that reflect management's current expectations, assumptions and estimates of future performance and economic conditions. Such statements are made in reliance upon the safe harbor provisions of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. The company cautions investors that any forward-looking statements are subject to risks and uncertainties that may cause actual results and future trends to differ materially from those matters expressed in or implied by such forward-looking statements. Statements about future capacity are forward-looking and involve risks and uncertainties. L3Harris disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.
Yahoo
16-05-2025
- Yahoo
How our clean-tech startup stumbled into a Pentagon partnership by following the demand
My love for our planet began as a child growing up in rural Canada. I'm a lifelong hiker, fisherman, animal lover, and mineral collector. These interests deepened my appreciation for the value of a healthy planet. When I moved to San Francisco, I set out to transform my passion for nature into clean-tech action. Over the next decade, I launched startups addressing major environmental challenges and worked as an advisor helping global blue-chip clients make their technologies more resilient, cost-effective, and profitable, all while being greener. After working in natural resources, I set out on my next big venture, founding Magrathea in 2022 right here in San Francisco to develop electrolytic technology capable of creating magnesium metal from seawater—metal that could be used to manufacture electric vehicles while emitting zero CO2 emissions and reducing humanity's need for terrestrial mining. But world events would soon reshape our trajectory in ways I never anticipated. Our first fundraise for Magrathea, in March 2022, coincided with a turning point I never expected: the start of Putin's full-scale invasion of the rest of Ukraine. I'm not proud to admit it—and want to be clear about that—but this horrific development, to our surprise, created momentum for Magrathea in an unexpected area: the defense industry. With the onset of the Ukraine war, the U.S. and other NATO countries immediately focused on shoring up their defenses and military spending. Almost all military products—Black Hawk helicopters, AI-powered drones, next-generation fighter jets—require magnesium. It's a critical component in making aluminum alloys stronger and is irreplaceable in a number of defense industry applications. Naturally, the U.S. and other NATO allies suddenly required more magnesium—and they turned to Magrathea. About a year later, we found ourselves in partnership with the U.S. Defense Department via a Defense Production Act Title III grant to further develop our technology to secure the U.S.'s defense industrial base. Magrathea's strategic pivot amidst the Ukraine war served as a valuable lesson. It illuminated a critical aspect of being successful with technological development: You have to make something the market wants. To deliver successful technology, helping the environment simply isn't enough. You need a viable technology solution in the short term with a proven end market and robust economics. Safeguarding the environment becomes a valuable byproduct, but for that benefit to be realized, the economics must work. In the case of magnesium, our end market is expansive—magnesium metal is perhaps the most important critical material, and it's the only structural metal you can make from seawater. You can't manufacture planes or cars without it. In addition to steel and aluminum, magnesium is also essential for titanium (aerospace applications), beryllium (electronics), and amorphous boron (defense)—as well as hafnium and zirconium (nuclear). Our confidence in meeting this demand stems from historical precedent: A legacy variation of our process was used by Dow Chemical in Freeport, Texas. Using this process, Dow helped the U.S. become the world's largest producer of magnesium metal, running the smelter for over 70 years until the late 1990s. We're building on this proven foundation with modern innovations including a major upgrade to the way magnesium chloride salt is processed before electrolysis. Where we really differ from our predecessors is that we believe we have cracked the code when it comes to producing magnesium in a cost-effective manner by developing a less-capital-intensive, more durable salt processing and electrolysis system. We have five patent applications and mountains of trade secrets protecting the innovations we've imbued on the electrolytic magnesium metal production process. We're a team of less than 20, but we've done more than a team of 50 could do in five years at a big company. As powerful and large as the market opportunity for magnesium is, having great technology is only the first step. What is most urgently needed is investment. To ensure America becomes a leader in critical minerals and other emerging industries, billions of dollars to fund large capital projects is what will truly move the needle. This is something I have been communicating to the U.S. federal government every time I talk to them. For us, while we can produce magnesium at a small scale and sell it to customers, we need more capital to build large-scale facilities to produce the amount of metal that our customers really need. To date, we have raised $12 million in private funding and have a $28 million partnership with the DOD, but this is only enough for us to develop our technology to pilot scale and improve processes. To take Magrathea to the next level, the government needs to understand that they must make capital available in the form of large grants and loan guarantees. The private investment industry is not going to figure this out on their own. We need the government to be first movers. America has viable, compelling technology solutions available today to address its critical minerals shortage, but they need immense capital to scale. The Chinese understand this, and they made such capital available to build up their crucial industries decades ago. Yet our government has repeatedly missed similar opportunities, allowing promising technologies, especially clean technologies like batteries and solar photovoltaics, to be sent to their graves before being scaled up. Climate solutions, national security, economic growth—these are not separate battles in my mind. They are one and the same. America has the chance to win them all, but that requires more than white papers, essays, and speeches. It requires focus, patience, and—most importantly—investment. There is a path forward to bring primary magnesium metal manufacturing back to the United States to bolster national security, and to drive growth of this important and valuable industry all while bringing climate solutions to market. Now, more than ever, America has a chance to turn innovation—provided we choose to invest in it—into leadership. As Magrathea enters the next stage of its journey—with plans to establish the first commercial electrolytic magnesium facility in the past 50 years—my climate passion is still very much with me. I don't know for certain that the rest of my journey will be without its pivots, but one thing I do know is that I'll never overlook the importance of building solutions that can help our planet. The opinions expressed in commentary pieces are solely the views of their authors and do not necessarily reflect the opinions and beliefs of Fortune. Read more: How our ping pong startup hit a $50M valuation in 5 years by tapping into automation How we built our bootstrapped startup different and sold it for $40M. (Hint: We ignored some myths) In 6 years I've bootstrapped my moving company to $100M in revenue. Avoiding VC funding has been key This story was originally featured on Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
14-05-2025
- Yahoo
Humacyte Inc (HUMA) Q1 2025 Earnings Call Highlights: A Turnaround with Symvess Launch and ...
Revenue: $517,000 for Q1 2025, including $147,000 from the US commercial launch of Symvess. Cost of Goods Sold: $147,000 for Q1 2025. Research and Development Expenses: $15.4 million for Q1 2025, down from $21.3 million in Q1 2024. General and Administrative Expenses: $8.1 million for Q1 2025, up from $5.3 million in Q1 2024. Other Net Income: $62.3 million for Q1 2025, compared to a net expense of $5.3 million in Q1 2024. Net Income: $39.1 million for Q1 2025, compared to a net loss of $31.9 million in Q1 2024. Cash, Cash Equivalents, and Restricted Cash: $113.2 million as of March 31, 2025. Net Cash Provided: $17.9 million for the first three months of 2025. Workforce Reduction: Approximately 31 employees, with estimated savings of $13.8 million in 2025 and up to $38 million in 2026. Warning! GuruFocus has detected 2 Warning Signs with HUMA. Release Date: May 13, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Humacyte Inc (NASDAQ:HUMA) successfully launched Symvess, a groundbreaking product for extremity vascular trauma, with initial shipments to three Level 1 trauma centers. The company has extended its cash runway through recent financing and cost reductions, allowing for aggressive expansion of its commercial launch. Symvess has been approved by the Value Analysis Committees (VACs) of five hospitals, with 45 hospitals currently evaluating the product. The publication of a Budget Impact Model in the Journal of Medical Economics demonstrates Symvess's economic value by reducing infections and amputations. Humacyte Inc (NASDAQ:HUMA) is making progress in the military market, with multiple military treatment facilities expressing interest in purchasing Symvess. The company faced unfounded negative press regarding Symvess, which created some headwinds in the VAC approval process. A reduction in workforce by approximately 31 employees was implemented to extend the cash runway, indicating financial constraints. The volatile economic environment poses challenges to the commercial launch and expansion efforts. The New York Times article created some pushback from VACs, requiring additional efforts to address concerns. The process for VAC approvals and sales is expected to be lengthy, with most sales anticipated in the second half of the year. Q: Can you provide insights into the experience of the three sites that have purchased Symvess and how the VAC process is progressing? A: Dr. Laura Niklason, President and CEO, explained that the first implant was successful, with sales reps present at some sites. The VAC approval process is progressing well, despite some initial setbacks due to negative press. BJ Scheessele, Chief Commercial Officer, added that the sales funnel is strong, with 45 submissions and five approvals, and they expect momentum to build in the second half of the year. Q: How does the ECAT process work for military and federal hospitals, and are there additional hurdles? A: Dr. Laura Niklason stated that once Symvess is listed on ECAT, military hospitals can order it, but surgeon champions are crucial. BJ Scheessele noted that they are working with a DoD procurement partner to facilitate the process, and military hospitals typically do not have a formal VAC process. Q: Are current sales force levels sufficient to cover military hospitals and Level 1 trauma centers? A: BJ Scheessele confirmed that the current sales force is adequate to cover existing targets and that they will consider expanding the team as success grows in both civilian and military markets. Q: Do current revenue estimates for 2025 remain reasonable given recent progress? A: Dale Sander, CFO, confirmed that they are comfortable with the guidance provided earlier, expecting most revenues to come in the second half of the year due to the VAC process. Q: What learnings from previous Phase III studies are being applied to the V012 trial? A: Dr. Laura Niklason highlighted the importance of managing the conduit in dialysis centers and ensuring adherence to clinical protocols. They are focusing on patient subgroups that struggle with fistulas, anticipating positive trial results. For the complete transcript of the earnings call, please refer to the full earnings call transcript. This article first appeared on GuruFocus.
